Cheri Ackerman

A leader in scientific innovation and a winner of the Emerging Women Founder Award, Cheri co-founded Concerto to reinvent humanity’s relationship with microbes. Cheri led Concerto to raise oversubscribed Seed and Series A investment rounds, fueling the company’s development of transformative microbial treatments and industry partnerships. Cheri has built a strong company culture centered around rigorous science, intent listening, and compassion. She holds a PhD in Chemistry from UC Berkeley (Hertz Fellow) and completed a postdoctoral fellowship at the Broad Institute of MIT and Harvard (NIH Kirschstein Fellow).